📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Concert Pharmaceuticals

1.1 - Company Overview

Concert Pharmaceuticals Logo

Concert Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage biotechnology developing drug products via a novel precision deuterium chemistry platform, modifying specific properties of validated drug molecules to create new medicines that address patient needs, yielding a rich pipeline.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Concert Pharmaceuticals

Adapt Pharma Logo

Adapt Pharma

HQ: United States Website
  • Description: Provider of therapeutic treatments for patients with special medical conditions, including NARCAN (naloxone hydrochloride) Nasal Spray, an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Adapt Pharma company profile →
Seaport Therapeutics Logo

Seaport Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical solutions, including the Glyph platform, a proprietary lymphatic-targeting technology enabling and enhancing oral drug administration by bypassing first-pass metabolism and reducing hepatotoxicity, and SPT-300, an oral prodrug of allopregnanolone for treating mood and anxiety disorders, including anxious depression.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Seaport Therapeutics company profile →
LB Pharmaceuticals Logo

LB Pharmaceuticals

HQ: United States Website
  • Description: Provider of development-stage CNS therapeutics focused on LB-102 (n-Methyl amisulpride), a modified amisulpride for schizophrenia, and clinical trials assessing its safety, efficacy, and pharmacokinetics. Also develops improved versions of CNS treatments widely used overseas but not FDA approved for commercialization in the United States.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full LB Pharmaceuticals company profile →
Pulsar Vascular Logo

Pulsar Vascular

HQ: United States Website
  • Description: Provider of an endovascular platform addressing bifurcation aneurysms, offering the PulseRider Neck Reconstruction Device, a neck-bridge solution designed to span the aneurysm neck and support and stabilize an embolic coil mass.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pulsar Vascular company profile →
Grass Technologies Logo

Grass Technologies

HQ: United States Website
  • Description: Provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders; designs and develops leading-edge products in neurology and other life science markets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Grass Technologies company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Concert Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Concert Pharmaceuticals

2.2 - Growth funds investing in similar companies to Concert Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Concert Pharmaceuticals

4.2 - Public trading comparable groups for Concert Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Concert Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Concert Pharmaceuticals

What does Concert Pharmaceuticals do?

Concert Pharmaceuticals is a provider of clinical-stage biotechnology developing drug products via a novel precision deuterium chemistry platform, modifying specific properties of validated drug molecules to create new medicines that address patient needs, yielding a rich pipeline.

Who are Concert Pharmaceuticals's competitors?

Concert Pharmaceuticals's competitors and similar companies include Adapt Pharma, Seaport Therapeutics, LB Pharmaceuticals, Pulsar Vascular, and Grass Technologies.

Where is Concert Pharmaceuticals headquartered?

Concert Pharmaceuticals is headquartered in United States.

How many employees does Concert Pharmaceuticals have?

Concert Pharmaceuticals has 1,000 employees 🔒.

When was Concert Pharmaceuticals founded?

Concert Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Concert Pharmaceuticals in?

Concert Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Concert Pharmaceuticals

Who are the top strategic acquirers in Concert Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Concert Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Concert Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Concert Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Concert Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Concert Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Concert Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Concert Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Concert Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Concert Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Concert Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Concert Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Concert Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Concert Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Concert Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Concert Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Concert Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Concert Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Concert Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Concert Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Concert Pharmaceuticals